BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 280 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2021. The put-call ratio across all filers is 1.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,921,076 | +243.4% | 595,800 | +245.4% | 0.09% | +135.1% |
| Q2 2022 | $8,712,000 | -79.7% | 172,482 | -58.8% | 0.04% | -80.4% |
| Q3 2021 | $42,995,000 | +87.4% | 418,200 | +60.3% | 0.19% | +83.5% |
| Q2 2021 | $22,944,000 | +36.6% | 260,844 | +24.4% | 0.10% | +17.0% |
| Q4 2019 | $16,801,000 | -34.6% | 209,729 | -25.1% | 0.09% | -17.8% |
| Q1 2018 | $25,672,000 | +14.2% | 279,957 | -6.1% | 0.11% | +10.3% |
| Q4 2017 | $22,473,000 | +2.0% | 298,009 | -5.8% | 0.10% | -1.0% |
| Q3 2017 | $22,030,000 | +9.2% | 316,200 | -20.6% | 0.10% | -13.3% |
| Q2 2017 | $20,172,000 | +389.7% | 398,108 | +286.5% | 0.11% | +391.3% |
| Q1 2017 | $4,119,000 | – | 103,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 581,768 | $25,487,256 | 9.57% |
| Casdin Capital, LLC | 1,477,800 | $64,742,418 | 5.02% |
| Nextech Invest Ltd. | 188,228 | $8,246,269 | 3.28% |
| DAFNA Capital Management LLC | 261,235 | $11,444,705 | 3.22% |
| Rock Springs Capital Management LP | 1,891,510 | $82,867,053 | 1.99% |
| HealthCor Management, L.P. | 30,000 | $1,314,300 | 1.20% |
| EFG Asset Management (North America) Corp. | 110,853 | $4,766,679 | 1.07% |
| Novo Holdings A/S | 370,000 | $16,209,700 | 1.01% |
| SECTORAL ASSET MANAGEMENT INC | 115,900 | $5,077,579 | 0.98% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 305,709 | $13,393,111 | 0.83% |